CADL insider transactions

SEC Form 4 filed by Chief Commercial Officer Sims Mark E.

SEC Form 3 filed by new insider Sims Mark E.

Chief Scientific Officer Barone Francesca sold $235,769 worth of shares (23,447 units at $10.06) as part of a pre-agreed trading plan, decreasing direct ownership by 23% to 77,362 units (SEC Form 4)

Chief Technology Officer Tyagarajan Seshu sold $70,151 worth of shares (7,000 units at $10.02) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 83,865 units (SEC Form 4)

SEC Form 4 filed by Director Manning Paul B

SEC Form 4 filed by Director Papa Joseph C

SEC Form 4 filed by Director Loggia Nicoletta

SEC Form 4 filed by Director Radhakrishnan Maha

SEC Form 4 filed by Director Loggia Nicoletta

SEC Form 4 filed by Director Papa Joseph C

SEC Form 4 filed by Director Benz Edward J. Jr

SEC Form 4 filed by Director Martell Christopher

SEC Form 4 filed by Director Gaeta Renee

SEC Form 4 filed by Director Nabel Gary J.

SEC Form 4 filed by Director Nguyen Diem

SEC Form 4 filed by Director Manning Paul B

SEC Form 4 filed by Manning Paul B

SEC Form 4 filed by Papa Joseph C

SEC Form 4 filed by Loggia Nicoletta

Director Manning Paul B bought $2,999,996 worth of shares (550,458 units at $5.45) (SEC Form 4)

SEC Form 4 filed by Chief Technology Officer Tyagarajan Seshu

SEC Form 4 filed by Chief Medical Officer Nichols William Garrett

SEC Form 4 filed by Chief Financial Officer Schoch Charles

SEC Form 4 filed by Chief Executive Officer Tak Paul Peter

SEC Form 4 filed by Chief Scientific Officer Barone Francesca

Chief Medical Officer Nichols William Garrett exercised 937 shares at a strike of $1.29 and sold $6,540 worth of shares (937 units at $6.98) (SEC Form 4)

Chief Medical Officer Nichols William Garrett exercised 781 shares at a strike of $1.29 and sold $3,936 worth of shares (781 units at $5.04) (SEC Form 4)

Director Manning Paul B was granted 1,070,663 shares (SEC Form 4)

Chief Executive Officer Tak Paul Peter was granted 42,826 shares, increasing direct ownership by 19% to 268,566 units (SEC Form 4)

Chief Technology Officer Tyagarajan Seshu was granted 5,353 shares, increasing direct ownership by 6% to 90,865 units (SEC Form 4)

Director Martell Christopher was granted 111,349 shares (SEC Form 4)

Director Papa Joseph C was granted 64,239 shares (SEC Form 4)

Director Loggia Nicoletta was granted 2,141 shares (SEC Form 4)

Chief Financial Officer Schoch Charles was granted 5,353 shares, increasing direct ownership by 14% to 43,391 units (SEC Form 4)

Director Nabel Gary J. was granted 5,353 shares (SEC Form 4)

Chief Scientific Officer Barone Francesca was granted 4,282 shares, increasing direct ownership by 4% to 100,809 units (SEC Form 4)

SEC Form 4 filed by Chief Financial Officer Schoch Charles

SEC Form 4 filed by Director Benz Edward J. Jr

SEC Form 4 filed by Director Gaeta Renee

SEC Form 4 filed by Director Loggia Nicoletta

SEC Form 4 filed by Director Manning Paul B

SEC Form 4 filed by Director Martell Christopher

SEC Form 4 filed by Director Nabel Gary J.

SEC Form 4 filed by Director Nguyen Diem

SEC Form 4 filed by Director Papa Joseph C

SEC Form 4 filed by Director Radhakrishnan Maha

SEC Form 3 filed by new insider Radhakrishnan Maha

Chief Scientific Officer Barone Francesca exercised 18,000 shares at a strike of $1.55 and sold $281,673 worth of shares (32,146 units at $8.76), decreasing direct ownership by 13% to 96,527 units (SEC Form 4)

Chief Medical Officer Nichols William Garrett exercised 18,489 shares at a strike of $1.90 and sold $396,995 worth of shares (45,316 units at $8.76), decreasing direct ownership by 34% to 52,493 units (SEC Form 4)

Chief Executive Officer Tak Paul Peter sold $229,624 worth of shares (26,172 units at $8.77), decreasing direct ownership by 10% to 225,740 units (SEC Form 4)

Amendment: Chief Technology Officer Tyagarajan Seshu exercised 20,000 shares at a strike of $1.29 and sold $275,947 worth of shares (31,278 units at $8.82), decreasing direct ownership by 12% to 85,512 units (SEC Form 4)

Chief Technology Officer Tyagarajan Seshu sold $275,947 worth of shares (31,278 units at $8.82), decreasing direct ownership by 27% to 85,512 units (SEC Form 4)

Officer Schoch Charles sold $44,169 worth of shares (5,000 units at $8.83), decreasing direct ownership by 12% to 38,038 units (SEC Form 4)

Large owner Aguilar-Cordova Estuardo returned $254,403 worth of CADL to the company (21,165 units at $12.02), decreasing direct ownership by 6% to 162,929 units (SEC Form 4)

SEC Form 4 filed by Officer Schoch Charles

SEC Form 4 filed by Chief Medical Officer Nichols William Garrett

SEC Form 4 filed by Chief Scientific Officer Barone Francesca

SEC Form 4 filed by Chief Executive Officer Tak Paul Peter

SEC Form 4 filed by Chief Technology Officer Tyagarajan Seshu

Large owner Aguilar-Cordova Estuardo returned $269,794 worth of CADL to the company (31,335 units at $8.61), decreasing direct ownership by 34% to 60,000 units (SEC Form 4)